Nanodelivery Systems Face Challenges and Limitations in Bone Diseases Management

Bone is a highly dynamic tissue. Hence, diseases affecting bone tissue, such as cancer (primary tumors and metastases), osteoporosis, and genetic conditions present many challenges for traditional therapies, leading to poor therapeutic outcome. Nano‐delivery systems are innovative tools used for the treatment of a variety of diseases due to their ability to deliver various therapeutic cargos and specifically target disease sites, including difficult ones like bone. A variety of nano‐delivery strategies are recently explored to treat bone‐related pathologies, with many resulting in better outcomes than traditional approaches. In this review, the authors cover recent attempts to use nano‐delivery systems for the treatment of skeletal‐related disorders including primary bone tumors, metastatic bone tumors, and non‐cancerous bone disorders. Finally, potential barriers for the translation of such new therapeutics into the clinic and possible methods to overcome these barriers, are discussed.

• Publication year

  2021

• Venue

  Advances in Therapy

• Publication date

  2021-10-18

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1002/adtp.202100152
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Lectin-conjugated pH-responsive mesoporous silica nanoparticles for targeted bone cancer treatment.

  2021cited by this paper
• MicroRNAs Modulate Signaling Pathways in Osteogenic Differentiation of Mesenchymal Stem Cells

  2021cited by this paper
• Advances in Nanomaterial-Mediated Photothermal Cancer Therapies: Toward Clinical Applications

  2021cited by this paper
• Long Non-coding RNAs and MicroRNAs Interplay in Osteogenic Differentiation of Mesenchymal Stem Cells

  2021cited by this paper
• Mesenchymal stromal cells mediated delivery of photoactive nanoparticles inhibits osteosarcoma growth in vitro and in a murine in vivo ectopic model

  2020cited by this paper
• Re-epithelialization and immune cell behaviour in an ex vivo human skin model

  2020cited by this paper
• Progress in Clinical Trials of Photodynamic Therapy for Solid Tumors and the Role of Nanomedicine

  2020cited by this paper
• Multimodal treatment including standard chemotherapy with vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for the Ewing sarcoma family of tumors in Japan: Results of the Japan Ewing Sarcoma Study 04

  2020cited by this paper
• Organ-on-a-chip platforms for accelerating the evaluation of nanomedicine

  2020cited by this paper
• Breaking the vicious cycle between tumor cell proliferation and bone resorption by chloroquine-loaded and bone-targeted polydopamine nanoparticles

  2020cited by this paper
• Reproducible and Characterized Method for Ponatinib Encapsulation into Biomimetic Lipid Nanoparticles as a Platform for Multi-Tyrosine Kinase-Targeted Therapy.

  2020cited by this paper
• The Bone Extracellular Matrix in Bone Formation and Regeneration

  2020cited by this paper
• Immuno-genomic landscape of osteosarcoma

  2020cited by this paper
• Zoledronate and SPIO dual-targeting nanoparticles loaded with ICG for photothermal therapy of breast cancer tibial metastasis

  2020cited by this paper
• Engineering precision nanoparticles for drug delivery

  2020cited by this paper
• Long-term storage of lipid-like nanoparticles for mRNA delivery

  2020cited by this paper
• What Went Wrong with Anticancer Nanomedicine Design and How to Make It Right.

  2020cited by this paper
• Bone Diseases: Current Approach and Future Perspectives in Drug Delivery Systems for Bone Targeted Therapeutics

  2020cited by this paper
• Key considerations in designing CRISPR/Cas9-carrying nanoparticles for therapeutic genome editing.

  2020cited by this paper
• Targeting nanoparticles for diagnosis and therapy of bone tumors: Opportunities and challenges.

  2020cited by this paper
• EGFR: An essential receptor tyrosine kinase-regulator of cancer stem cells.

  2020cited by this paper
• Bioinspired Extracellular Vesicles: Lessons Learned From Nature for Biomedicine and Bioengineering

  2020cited by this paper
• Bone metastases

  2020cited by this paper
• Synthetic multi-layer nanoparticles for CRISPR-Cas9 genome editing.

  2020cited by this paper
• Biomimetic Nanoparticles Potentiate the Anti-Inflammatory Properties of Dexamethasone and Reduce the Cytokine Storm Syndrome: An Additional Weapon against COVID-19?

  2020cited by this paper
• Hydroxyapatite-dextran methacrylate core/shell hybrid nanocarriers for combinatorial drug therapy

  2020cited by this paper
• Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates.

  2020cited by this paper
• Molecular principles of metastasis: a hallmark of cancer revisited

  2020cited by this paper
• Non-Conventional Treatments for Conventional Chondrosarcoma

  2020cited by this paper
• Patient-Derived Cancer Models

  2020cited by this paper
• 3D In Vitro Model (R)evolution: Unveiling Tumor-Stroma Interactions.

  2020cited by this paper
• A framework for designing delivery systems

  2020cited by this paper
• Thirty Years of Cancer Nanomedicine: Success, Frustration, and Hope

  2019cited by this paper
• Bone mineral: new insights into its chemical composition

  2019cited by this paper
• Innovative Biomaterials for Bone Regrowth

  2019cited by this paper
• Methotrexate an Old Drug with New Tricks

  2019cited by this paper
• Tailoring Synthetic Melanin Nanoparticles for Enhanced Photothermal Therapy.

  2019cited by this paper
• Hydroxylapatite‐collagen hybrid scaffold induces human adipose‐derived mesenchymal stem cells to osteogenic differentiation in vitro and bone regrowth in patients

  2019cited by this paper
• Superparamagnetic Iron Oxide Nanoparticles—Current and Prospective Medical Applications

  2019cited by this paper
• Macrophage-derived nanovesicles exert intrinsic anti-inflammatory properties and prolong survival in sepsis through a direct interaction with macrophages.

  2019cited by this paper
• Polymers for cytosolic protein delivery.

  2019cited by this paper
• Tumor ablation using novel photothermal NaxWO3 nanoparticles against breast cancer osteolytic bone metastasis

  2019cited by this paper
• New Osteoporosis Treatment Means New Bone Formation.

  2019cited by this paper
• Birth Defects

  2019cited by this paper
• Osteogenesis Imperfecta: New Perspectives From Clinical and Translational Research

  2019cited by this paper
• Current trends and challenges in cancer management and therapy using designer nanomaterials

  2019cited by this paper
• Near-infrared-induced IR780-loaded PLGA nanoparticles for photothermal therapy to treat breast cancer metastasis in bones

  2019cited by this paper
• The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors

  2019cited by this paper
• Legg-Calvé-Perthes disease

  2019cited by this paper
• Lipid-polymer nanoparticles with CD133 aptamers for targeted delivery of all-trans retinoic acid to osteosarcoma initiating cells.

  2019cited by this paper
• Mesoporous Silica Nanoparticles as a Prospective and Promising Approach for Drug Delivery and Biomedical Applications.

  2019cited by this paper
• Adult Stem Cells for Bone Regeneration and Repair

  2019cited by this paper
• Three-dimensional cell culture systems as an in vitro platform for cancer and stem cell modeling

  2019cited by this paper
• Reversal of Osteoporotic Activity by Endothelial Cell-Secreted Bone Targeting and Biocompatible Exosomes.

  2019cited by this paper
• Modelling cancer in microfluidic human organs-on-chips

  2019cited by this paper
• Current review of surgical management options for extremity bone sarcomas

  2019cited by this paper
• Leukocyte-mimicking nanovesicles for effective doxorubicin delivery to treat breast cancer and melanoma.

  2019cited by this paper
• Radionuclides transform chemotherapeutics into phototherapeutics for precise treatment of disseminated cancer

  2018cited by this paper
• A Model of Chronic Exposure to Unpredictable Mild Socio-Environmental Stressors Replicates Some Spaceflight-Induced Immunological Changes

  2018cited by this paper
• A phase II study of temsirolimus and liposomal doxorubicin for patients with recurrent and refractory bone and soft tissue sarcomas

  2018cited by this paper
• Nanoformulations of anticancer FGFR inhibitors with improved therapeutic index.

  2018cited by this paper
• Bisphosphonate conjugation for bone specific drug targeting

  2018cited by this paper
• Understanding the Bone in Cancer Metastasis

  2018cited by this paper
• Functionalized Keratin as Nanotechnology-Based Drug Delivery System for the Pharmacological Treatment of Osteosarcoma

  2018cited by this paper
• Recent biomedical applications of gold nanoparticles: A review.

  2018cited by this paper
• Zinc phthalocyanine encapsulated in polymer micelles as a potent photosensitizer for the photodynamic therapy of osteosarcoma.

  2018cited by this paper
• Assessment of a novel nanoparticle hyperthermia therapy in a murine model of osteosarcoma

  2018cited by this paper
• Preclinical three‐dimensional colorectal cancer model: The next generation of in vitro drug efficacy evaluation

  2018cited by this paper
• Editorial: Adverse Effects of Cancer Chemotherapy: Anything New to Improve Tolerance and Reduce Sequelae?

  2018cited by this paper
• Bone physiology as inspiration for tissue regenerative therapies.

  2018cited by this paper
• Safety and efficacy of high‐dose methotrexate for osteosarcoma in adolescents compared with young adults

  2018cited by this paper
• Targeted Nanomedicine to Treat Bone Metastasis

  2018cited by this paper
• Chondrosarcoma: biology, genetics, and epigenetics

  2018cited by this paper
• SN-38 Conjugated Gold Nanoparticles Activated by Ewing Sarcoma Specific mRNAs Exhibit In Vitro and In Vivo Efficacy.

  2018cited by this paper
• Multifunctional melanin-like nanoparticles for bone-targeted chemo-photothermal therapy of malignant bone tumors and osteolysis.

  2018cited by this paper
• Stimuli‐responsive nanocarriers for delivery of bone therapeutics – Barriers and progresses

  2018cited by this paper
• Nanoparticles for Immune Cytokine TRAIL-Based Cancer Therapy.

  2018cited by this paper
• Targeted salinomycin delivery with EGFR and CD133 aptamers based dual-ligand lipid-polymer nanoparticles to both osteosarcoma cells and cancer stem cells.

  2018cited by this paper
• Paget's Disease of Bone: Diagnosis and Treatment.

  2018cited by this paper
• Biomimetic nanoparticles with enhanced affinity towards activated endothelium as versatile tools for theranostic drug delivery

  2018cited by this paper
• Combination therapy in combating cancer

  2017cited by this paper
• The role of radiation therapy in bone metastases management

  2017cited by this paper
• Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions

  2017cited by this paper
• Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group.

  2017cited by this paper
• Is intralesional resection suitable for central grade 1 chondrosarcoma: A systematic review and updated meta-analysis.

  2017cited by this paper
• Application of Sodium Selenite in the Prevention and Treatment of Cancers

  2017cited by this paper
• Challenges and strategies in anti-cancer nanomedicine development: An industry perspective.

  2017cited by this paper
• Osteogenesis Imperfecta

  2017cited by this paper
• Bone-Induced Expression of Integrin β3 Enables Targeted Nanotherapy of Breast Cancer Metastases.

  2017cited by this paper
• Delivery strategies of the CRISPR‐Cas9 gene‐editing system for therapeutic applications

  2017cited by this paper
• Editorial: Bone: Endocrine Target and Organ

  2017cited by this paper
• Mesenchymal stroma: Role in osteosarcoma progression.

  2017cited by this paper
• Unveiling the in Vivo Protein Corona of Circulating Leukocyte-like Carriers.

  2017cited by this paper
• Improving radiotherapy in cancer treatment: Promises and challenges

  2017cited by this paper
• Aptamer-Based Therapeutic Approaches to Target Cancer Stem Cells

  2017cited by this paper
• Tumour-on-a-chip: microfluidic models of tumour morphology, growth and microenvironment

  2017cited by this paper
• In vivo pharmacological evaluation and efficacy study of methotrexate-encapsulated polymer-coated layered double hydroxide nanoparticles for possible application in the treatment of osteosarcoma

  2017cited by this paper
• Chlorin e6 Functionalized Theranostic Multistage Nanovectors Transported by Stem Cells for Effective Photodynamic Therapy.

  2017cited by this paper
• Osteogenesis imperfecta

  2016cited by this paper
• mTOR inhibitors in cancer therapy

  2016cited by this paper

• Smart biomaterials for skeletal aging repair and regeneration

  2026cites this paper
• Emerging viroporins, RBP dynamics, and skeletal remodeling: Targeting liquid-liquid phase separation for dual antiviral and bone-protective therapies.

  2026cites this paper
• Recent strides in lipid-based nanoparticle-mediated co-delivery systems for bone cancer management: A comprehensive review

  2026cites this paper
• Recent advances in metal-based nanomaterials for malignant bone tumor therapy.

  2025cites this paper
• Nanotechnology for understanding the tumor microenvironment heterogeneity in bone carcinoma

  2025cites this paper
• Comprehensive Insights into Osteoporosis: En-route from Conventional therapeutics to Nanotechnology-Based Approaches

  2025cites this paper
• RNA therapies for musculoskeletal conditions.

  2024cites this paper
• Combination Treatment with Liposomal Doxorubicin and Inductive Moderate Hyperthermia for Sarcoma Saos-2 Cells

  2024cites this paper
• Luminescent Alendronic Acid-Conjugated Micellar Nanostructures for Potential Application in the Bone-Targeted Delivery of Cholecalciferol

  2024cites this paper
• Advancements in neurotherapeutics: nanoparticles overcoming the blood–brain barrier for precise CNS targeting

  2024cites this paper
• Recent advances in drug delivery systems for osteosarcoma therapy and bone regeneration

  2024cites this paper
• Engineering of Bioresorbable Polymers for Tissue Engineering and Drug Delivery Applications

  2024cites this paper
• Biomimetic approaches for targeting tumor inflammation.

  2022cites this paper
• Tyrosine kinase inhibitor-loaded biomimetic nanoparticles as a treatment for osteosarcoma

  2022cites this paper